1. Home
  2. FGNX vs NSPR Comparison

FGNX vs NSPR Comparison

Compare FGNX & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FGNX

Fundamental Global Inc.

N/A

Current Price

$8.28

Market Cap

44.1M

Sector

Finance

ML Signal

N/A

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.89

Market Cap

40.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FGNX
NSPR
Founded
1932
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.1M
40.7M
IPO Year
2014
2009

Fundamental Metrics

Financial Performance
Metric
FGNX
NSPR
Price
$8.28
$0.89
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$35.00
$4.00
AVG Volume (30 Days)
112.3K
90.1K
Earning Date
05-19-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$32,023,000.00
$2,310,000.00
Revenue This Year
$650.31
$57.98
Revenue Next Year
N/A
$95.41
P/E Ratio
N/A
N/A
Revenue Growth
20.70
N/A
52 Week Low
$1.59
$0.63
52 Week High
$13.70
$2.57

Technical Indicators

Market Signals
Indicator
FGNX
NSPR
Relative Strength Index (RSI) 59.43 58.03
Support Level $5.64 $0.86
Resistance Level $9.17 $1.03
Average True Range (ATR) 0.68 0.08
MACD 0.04 0.00
Stochastic Oscillator 73.24 40.09

Price Performance

Historical Comparison
FGNX
NSPR

About FGNX Fundamental Global Inc.

FG Nexus Inc operates through two primary segments: Digital Assets and Merchant Banking, with Digital Assets contributing the majority of revenue. The Company functions as a digital asset treasury, mainly holding Ethereum (ETH) and exploring opportunities in the tokenization of real-world assets, leveraging ETH as the foundation for digital finance, stablecoins, DeFi, and tokenized assets. The Merchant Banking segment offers strategic, administrative, and regulatory support to newly formed SPACs through the Company's SPAC platform.

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

Share on Social Networks: